CombiGene publishes the prospectus for the rights issue

CombiGene AB (publ) (”CombiGene” or ”the Company”) publishes this prospectus pursuant to a resolution by the board of CombiGene AB on 22 August 2018 to introduce a preference issue of units (”the Issue”). Full subscription of the offer will generate about MSEK 31.0 before deductions for issuing expenses.


“This is an English translation of the Swedish website; if there is any inconsistency or ambiguity between the English version and the Swedish version, the Swedish version shall prevail. For a complete list of regulatory-related press releases, please refer to the Swedish website”